Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What You Need to Know About Mondelez International Inc (MDLZ)’s Earnings

Page 1 of 2

Mondelez International Inc (NASDAQ:MDLZ) reported fourth-quarter and full-year 2012 earnings after the market closed on Wednesday. Let’s first review where the company’s been. Then we’ll dive into what you need to know about its recent results.

Once upon a time
Formerly known as Kraft Foods, Mondelez International completed its early October 2012 spinoff of Kraft Foods Group Inc (NASDAQ:KRFT). Considered the more sluggish of the two, North American grocery business Kraft Foods Group is home to billion-dollar brands Velveeta, Jell-O, and Oscar Mayer. Mondelez retained the higher-growing, higher-margin global snack foods business, including Oreo, Nabisco, and Cadbury brands.

Let’s take a closer look at Mondelez’s most recent results.

Mondelez International Inc (NASDAQ:MDLZ)“Transformational year” ended sluggishly
For the fourth quarter, Mondelez International missed slightly on revenues and on earnings-per-share estimates. The company claims fourth-quarter sales missed forecasts because it lowered coffee prices in Europe to keep up with rivals. However, the company again reaffirmed its 2013 organic net revenue growth outlook to be at the low end of its 5% to 7% growth target. Mondelez asserts it can pick up steam in the second half of the year.

Compared to the prior-year quarter, earnings dropped significantly. Net profit was $0.30 per share in fourth-quarter 2012, down from $0.47 per share a year earlier, before its split from Kraft. But the company increased its full-year EPS guidance to $1.52 to $1.57.

Mondelez stock is down roughly 3% so far in Thursday’s trading.

Help from developing markets
The key growth driver for Mondelez remains emerging markets. With the Kraft Foods Group spinoff, Mondelez retained the global piece of the business. Mondelez currently derives 44% of its revenues from emerging markets, but it’s aiming for a bigger piece of the pie. Changes in snacking habits worldwide may likely turn that vision into a reality, since global snack food consumption is expected to grow 7% annually by 2015.

In developing markets, Mondelez enjoyed a 12% revenue increase for the full-year 2012 from several of its “Power Brands,” including Oreo cookies and Cadbury, Milka, and Lacta chocolates.

Mondelez delivered mixed fourth-quarter results in developing markets, with growth in Asia-Pacific and Latin America, specifically in India, Brazil, and Argentina. The company experienced 20% growth in India, but suffered from capacity constraints in the emerging-market nation.

Rival chocolate maker The Hershey Company (NYSE:HSY) has also recently enjoyed sweet success in emerging markets. The company’s fourth-quarter revenue grew nearly 12% compared to a year earlier, and helped Hershey finish 2012 on solid footing. These tasty results endorse Hershey’s strategy of investing in key international markets, notably South America and China. In fact, Hershey sales were up 50% last quarter in China.

Confectioneries remain sweet, gum still sticky
Mondelez’s greatest opportunity lies in its fast-growing confectionery category. Higher-margin confectioneries typically enjoy higher growth rates and fewer private-label threats compared to other food categories. Chocolates, gums, and candies under Mondelez’s Cadbury, Milka, Toblerone, Trident, and Stride labels represent over 40% of company revenues.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!